The global market for fertility medicine is now $30-40 billion per year, but many continue to view it as a women's health problem. Episona hopes to change that, with its epigenetics-based male fertility test.
Epigenetics Startup Episona Launches Male Fertility Test
Comment
Show comments
Hide Comments
